Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer
about
IRF7: activation, regulation, modification and functionThe transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expressionTargeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseInsights into interferon regulatory factor activation from the crystal structure of dimeric IRF5Structures of apo IRF-3 and IRF-7 DNA binding domains: effect of loop L1 on DNA bindingThe crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factorMechanism of Origin DNA Recognition and Assembly of an Initiator-Helicase Complex by SV40 Large Tumor AntigenThe role of response elements organization in transcription factor selectivity: the IFN-β enhanceosome exampleDNA structure modulates the oligomerization properties of the AAV initiator protein Rep68.Structural insights into interferon regulatory factor activation.Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production.Relative quantification of protein-protein interactions using a dual luciferase reporter pull-down assay system.Absence of a simple code: how transcription factors read the genomeTranscription factor redundancy ensures induction of the antiviral stateMind-controlled transgene expression by a wireless-powered optogenetic designer cell implant.Model of a DNA-protein complex of the architectural monomeric protein MC1 from Euryarchaea.HSPD1 interacts with IRF3 to facilitate interferon-beta induction.Limited specificity of IRF3 and ISGF3 in the transcriptional innate-immune response to double-stranded RNA.Enhanceosome transcription factors preferentially dimerize with high mobility group proteins.Effects of Different Doses of Nucleocapsid Protein from Hantaan Virus A9 Strain on Regulation of Interferon Signaling.Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins.Genomics and the immune system.Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virusBunyaviruses and the type I interferon system.The IKK Kinases: Operators of Antiviral Signaling.Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication.The specificity of innate immune responses is enforced by repression of interferon response elements by NF-κB p50DNA-binding landscape of IRF3, IRF5 and IRF7 dimers: implications for dimer-specific gene regulation.
P2860
Q24299740-83A21DE8-1FDB-40D2-B221-E23551FBCFD6Q24336528-6E18E7B9-E8FC-436E-A0A3-F72010EE0F71Q24625246-A1A10346-91FF-496E-AAD7-AB3587DF6DA8Q26750725-910F1EFD-9A1A-4534-9115-B85C0787D9B5Q27652424-1B2C2CA9-D090-4293-9C3A-F770F2C4D4F3Q27667901-B0D3600C-D609-4441-8822-15D25155B8C3Q27676606-E9A422FA-87D3-455C-AF63-06C1CB0BB7EEQ27677146-12BCA131-FB07-4904-8F72-7216C9AEB1C4Q28478618-82AF441A-594B-40C3-A0FE-B3B32F59D409Q33480968-9F4F55F3-2640-4F56-9A59-9F98337DF099Q33756083-A8EA76C1-AA3B-425A-910B-5ED6037392C6Q33924436-C8127AE2-8A66-4523-89A2-2B85AEA51E05Q34062413-D926FC27-A6CB-4125-A57D-9EABFEB7F848Q34111752-CC90BA98-B80D-4FCE-9E82-ADED46553069Q34439072-06DBB066-6E01-4314-A768-AF6DA410F0C2Q34563731-941B8CF6-66E7-4A01-834A-4DFBD40CAA0AQ35099697-C0CFFAFA-6BFF-4142-9770-D3F5697A6700Q35519523-267C4709-E8E2-4BDF-A11F-A28D91B5CC15Q35741748-71D28F1C-9620-4C06-8957-1CD64104CEF0Q35915154-AFBDAB4A-B036-4AEC-92C7-342A9F5BE50DQ36140317-0EB06795-2C97-495E-87C5-C95F9C9DF45DQ37021757-610025D4-C8F9-4530-B501-3DE3FE44A56BQ37093971-02042B73-98D2-4797-B826-420F976FEED5Q37428647-5FAD9975-C44A-41FC-A544-ED92EEC78C79Q38613824-F25B1C8C-5C8B-4DDD-8718-2393E6BC348EQ38614040-955378B5-04DF-473D-B30F-9481A450B68DQ38765368-8FE0B04B-27E9-470B-B6BE-009D1FDE7B2BQ39587742-885D35D9-18C8-4923-8587-253ACB026682Q47549814-5416EDE2-988D-4F8F-94FD-B98A1C456246
P2860
Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@ast
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@en
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@nl
type
label
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@ast
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@en
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@nl
prefLabel
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@ast
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@en
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@nl
P2093
P3181
P1433
P1476
Structure of IRF-3 bound to th ...... human interferon-beta enhancer
@en
P2093
Aneel K Aggarwal
Carlos R Escalante
P304
P3181
P356
10.1016/J.MOLCEL.2007.04.022
P577
2007-06-08T00:00:00Z